Drug Therapy

John D. Clough, MD
Editor in Chief

John D. Clough, MD
Editor in Chief

John D. Clough, MD
Editor in Chief

David J. Muzina, MD
Director, Adult Psychiatry Inpatient Unit, Department of Psychiatry and Psychology, Cleveland Clinic

Samar El-Sayegh, MD
Department of Psychiatry and Psychology, Cleveland Clinic

Address: David J. Muzina, MD, Department of Psychiatry and Psychology, P57, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

David J. Muzina, MD
Director, Adult Psychiatry Inpatient Unit, Department of Psychiatry and Psychology, Cleveland Clinic

Samar El-Sayegh, MD
Department of Psychiatry and Psychology, Cleveland Clinic

Address: David J. Muzina, MD, Department of Psychiatry and Psychology, P57, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

David J. Muzina, MD
Director, Adult Psychiatry Inpatient Unit, Department of Psychiatry and Psychology, Cleveland Clinic

Samar El-Sayegh, MD
Department of Psychiatry and Psychology, Cleveland Clinic

Address: David J. Muzina, MD, Department of Psychiatry and Psychology, P57, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Onyekachi Ifudu, MBBS, MSc
Department of Medicine, State University of New York Downstate Medical Center, Brooklyn, New York

Address: Onyekachi Ifudu, MBBS, MSc, SUNY Downstate Medical Center, Renal Disease Division, Box 52, 450 Clarkson Avenue, Brooklyn, NY 11203; [email protected]

Onyekachi Ifudu, MBBS, MSc
Department of Medicine, State University of New York Downstate Medical Center, Brooklyn, New York

Address: Onyekachi Ifudu, MBBS, MSc, SUNY Downstate Medical Center, Renal Disease Division, Box 52, 450 Clarkson Avenue, Brooklyn, NY 11203; [email protected]

Onyekachi Ifudu, MBBS, MSc
Department of Medicine, State University of New York Downstate Medical Center, Brooklyn, New York

Address: Onyekachi Ifudu, MBBS, MSc, SUNY Downstate Medical Center, Renal Disease Division, Box 52, 450 Clarkson Avenue, Brooklyn, NY 11203; [email protected]

Dennis L. Sprecher, MD
Head, Section of Preventive Cardiology and Rehabilitation, Department of Cardiology, Cleveland Clinic

Joseph P. Frolkis, MD, PhD
Section of Preventive Cardiology and Rehabilitation, Department of Cardiology, Cleveland Clinic

Address: Dennis L. Sprecher, MD, Department of Preventive Cardiology, C51, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Drs. Sprecher and Frolkis serve on the speakers’ bureaus of numerous pharmaceutical corporations.

Dennis L. Sprecher, MD
Head, Section of Preventive Cardiology and Rehabilitation, Department of Cardiology, Cleveland Clinic

Joseph P. Frolkis, MD, PhD
Section of Preventive Cardiology and Rehabilitation, Department of Cardiology, Cleveland Clinic

Address: Dennis L. Sprecher, MD, Department of Preventive Cardiology, C51, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Drs. Sprecher and Frolkis serve on the speakers’ bureaus of numerous pharmaceutical corporations.

Dennis L. Sprecher, MD
Head, Section of Preventive Cardiology and Rehabilitation, Department of Cardiology, Cleveland Clinic

Joseph P. Frolkis, MD, PhD
Section of Preventive Cardiology and Rehabilitation, Department of Cardiology, Cleveland Clinic

Address: Dennis L. Sprecher, MD, Department of Preventive Cardiology, C51, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Drs. Sprecher and Frolkis serve on the speakers’ bureaus of numerous pharmaceutical corporations.

Ann Marie Hake, MD
Department of Neurology, Indiana University School of Medicine

Address: Ann Marie Hake, MD, Department of Neurology, Indiana University School of Medicine, 541 Clinical Drive, Room 583, Indianapolis, IN 46202; [email protected]

Dr. Hake has indicated she is on the speakers bureau of the Novartis, Pfizer, Eisai, and Janssen corporations.

This paper discusses therapies that are not yet approved by the US Food and Drug Administration for the use under discussion.

Ann Marie Hake, MD
Department of Neurology, Indiana University School of Medicine

Address: Ann Marie Hake, MD, Department of Neurology, Indiana University School of Medicine, 541 Clinical Drive, Room 583, Indianapolis, IN 46202; [email protected]

Dr. Hake has indicated she is on the speakers bureau of the Novartis, Pfizer, Eisai, and Janssen corporations.

This paper discusses therapies that are not yet approved by the US Food and Drug Administration for the use under discussion.

Ann Marie Hake, MD
Department of Neurology, Indiana University School of Medicine

Address: Ann Marie Hake, MD, Department of Neurology, Indiana University School of Medicine, 541 Clinical Drive, Room 583, Indianapolis, IN 46202; [email protected]

Dr. Hake has indicated she is on the speakers bureau of the Novartis, Pfizer, Eisai, and Janssen corporations.

This paper discusses therapies that are not yet approved by the US Food and Drug Administration for the use under discussion.

Robert B. Gerber, MD
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Mani Kavuru, MD
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Address: Mani Kavuru, MD, Department of Pulmonary and Critical Care Medicine, A90,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Dr. Kavuru is on the speakers’ bureau of and has received grant support from the Glaxo Corporation.

Robert B. Gerber, MD
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Mani Kavuru, MD
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Address: Mani Kavuru, MD, Department of Pulmonary and Critical Care Medicine, A90,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Dr. Kavuru is on the speakers’ bureau of and has received grant support from the Glaxo Corporation.

Robert B. Gerber, MD
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Mani Kavuru, MD
Department of Pulmonary and Critical Care Medicine, Cleveland Clinic

Address: Mani Kavuru, MD, Department of Pulmonary and Critical Care Medicine, A90,  Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Dr. Kavuru is on the speakers’ bureau of and has received grant support from the Glaxo Corporation.